Angelfish Investments plc
(“Angelfish” or the “Company”)
Angelfish Investments plc announces that it has today raised GBP 90,000 by way of a placing (the “Placing”) of 72,000,000 new ordinary shares of 0.01p each (“Ordinary Shares”) to St Gallen Capital Limited and SVS Securities Plc at an issue price of 0.125p per Ordinary Share (the “Placing Price”).
The new Ordinary Shares issued in the Placing rank pari passu in all respects with the existing fully paid Ordinary Shares. The new Ordinary Shares issued in the Placing and the existing Ordinary Shares each have one right to vote per share. Following the Placing the Company will have 362,082,349 Ordinary Shares in issue.
The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in the Company under the FSA’s Disclosure and Transparency Rules. The Company’s total issued share capital is now £36,208.23.
Prior to the Placing, St Gallen Capital Limited beneficially held a total of 217,561,762 Ordinary Shares, which represented 217,561,762 voting rights. Prior to the Placing, St Gallen Capital Limited’s holding represented 75.00% of the voting rights in the then issued ordinary share capital of the Company. As such, the purchase of new Ordinary Shares in the Placing by St Gallen Capital Limited constitutes a related party transaction under the PLUS Rules for Issuers.
Following the Placing, St Gallen Capital Limited is now the beneficial holder of a total of 277,561,762 Ordinary Shares, which represents 277,561,762 voting rights. St Gallen Capital Limited’s total holding now represents 76.66% of the voting rights in the enlarged issued ordinary share capital of the Company.
Following the Placing, SVS Securities Plc is now the beneficial holder of a total of 12,000,000 Ordinary Shares, which represents 12,000,000 voting rights. SVS Securities Plc’s total holding represents 3.31% of the voting rights in the enlarged issued ordinary share capital of the Company.
Angelfish Director Andrew Flitcroft continues to beneficially hold a total of 4,077,844 ordinary shares (representing 4,077,844 voting rights), which now represents 1.13% of the voting rights in the enlarged issued ordinary share capital of the Company.
The net proceeds of the Placing will be used to augment the Company’s working capital reserves, and in particular to fund the due diligence necessary to further the Company’s investment strategy, which was approved by shareholders on 30 April 2012.
THE DIRECTORS OF THE COMPANY ACCEPT RESPONSIBILITY FOR THE CONTENTS OF THIS ANNOUNCEMENT.